Stock RDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-06 pm EDT 		5-day change 1st Jan Change
74.88 USD -0.44% Intraday chart for Dr. Reddy's Laboratories Limited +0.62% +7.62%
May. 06 Indian shares set to open higher on Fed rate-cut hopes RE
May. 03 Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indian shares set to open higher on Fed rate-cut hopes
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher
Dr. Reddy's Laboratories Launches Generic Doxycycline Capsules in US
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg in the U.S
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
Banking Stocks Lift Indian Equities Higher
Dr. Reddy's Laboratories Names CEO-North America
Dr. Reddy's Laboratories Limited Announces Executive Changes
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
Dr. Reddy's Laboratories Limited Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 Mg Due to Sub-Potency
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
Dr. Reddy's Laboratories Limited Receives Complete Response Letter from FDA to Biologics License Application
India's Biocon developing its own version of Wegovy, clinical trial likely next year
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. RDY Stock
  5. News Dr. Reddy's Laboratories Limited
  6. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW